课题基金 / 基金详情

项目摘要

项目成果

ALESSANDRA B PERNIS的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 尽管在我们对致病机制的理解上取得了重大进展,但 系统性红斑狼疮(SLE)的发展许多SLE患者的生活质量仍然很差 可控疾病。我们开发治疗系统性红斑狼疮新疗法的能力的一个主要障碍是 伴随这种障碍的异质性,部分原因是T助手和调节性T细胞的复杂性 细胞子集。在TH亚群中,TFH细胞在狼疮发病中起主要作用,因为它们在 驱使人们做出幽默反应。TFH细胞的发育需要Bcl6,Bcl6的过度表达足以驱动 TFH分化提示严密控制Bcl6的表达是确保TFH正确调控的关键 手机号码。使用缺乏DEF6和SWAP-70的小鼠(DKO小鼠),这是一个独特的免疫家族的两个成员 监管者的缺席导致狼疮的自发发展,我们最近发现了一个新的 调控Bcl6表达和TFH细胞增殖的机制。的确,DKO小鼠表现出 Bcl6异常翻译导致TFH细胞积聚。Bcl6在DKO TH细胞中的翻译增加是 MTORC1激活增强的结果,继而是调节一种蛋白的组装的途径的异常控制 Raptor-P62-TRAF6复合体。蛋白质组学方法证明在DKO中增强的Bcl6翻译 细胞伴随着选定数量的蛋白质的异常表达。除了细胞固有之外 TFH细胞异常、TFH细胞及其特化效应细胞协调发育失衡 Treg亚群,即滤泡调节性T(TFR)细胞,也可以促进自身免疫。试析《Treg》 DKO小鼠的群体显示TFR细胞有缺陷的扩张,但非TFR细胞的强劲积累 效应器特雷格斯。在这个提案中,我们将探索这样一个假设,即TFH细胞的异常能力可以利用 翻译机制加上TFR细胞亚群的缺陷可导致全身自身免疫。我们会 还要调查相关假设,即虽然TFR细胞中的缺陷会助长异常自身抗体的产生, 非TFR效应器Tregs的同时扩张可以帮助限制由这些促进的组织损伤 AutoAbs。具体地说,我们将:1)描述依赖mTORC1的翻译的调节和作用 在TFH细胞中编程,以及2)在狼疮中剖析控制效应器Treg亚群的通路。而当 系统性红斑狼疮的转录异常已被广泛研究,异常翻译的影响 狼疮T细胞的功能机制尚未引起足够的重视。因此,这些研究将提供关键的 关于新的调查领域的信息,并可能发现治疗干预的新靶点。一个 更好地了解不同Treg亚群在狼疮中的参与可以进一步提供新的 对伴随这种疾病的异质性的洞察以及对这一代人的重要信息 体外功能Tregs,这可能是最适合特定靶向SLE的。
英文摘要
ABSTRACT Despite significant advances in our understanding of the pathogenic mechanisms responsible for the development of Systemic Lupus Erythematosus (SLE) many patients with SLE continue to live with poorly controlled disease. A major roadblock in our ability to develop novel treatments for SLE is the significant heterogeneity that accompanies this disorder, which is partly due to the complexity of T helper and regulatory T cell subsets. Amongst TH subsets, TFH cells play a major role in lupus pathogenesis due to their crucial role in driving humoral responses. TFH cell development requires Bcl6 and overexpression of Bcl6 is sufficient to drive TFH differentiation indicating that tight control of Bcl6 expression is essential to ensure proper regulation of TFH cell numbers. Using mice lacking DEF6 and SWAP-70 (DKO mice), two members of a unique family of immune regulators whose absence leads to the spontaneous development of lupus, we have recently uncovered a new mechanism controlling the expression of Bcl6 and the expansion of TFH cells. Indeed DKO mice exhibit an accumulation of TFH cells due to aberrant translation of Bcl6. Increased translation of Bcl6 in DKO TH cells is the result of enhanced mTORC1 activation secondary to aberrant control of a pathway regulating the assembly of a raptor-p62-TRAF6 complex. A proteomic approach demonstrated that enhanced Bcl6 translation in DKO TH cells is accompanied by dysregulated expression of a selected number of proteins. In addition to cell-intrinsic abnormalities in TFH cells, imbalances in the coordinated development of TFH cells and its specialized effector Treg subset, follicular regulatory T (TFR) cells, can also promote autoimmunity. An analysis of the Treg population in DKO mice has revealed a defective expansion of TFR cells but a robust accumulation of non-TFR effector Tregs. In this proposal we will explore the hypothesis that an aberrant ability of TFH cells to employ translational mechanisms coupled with defects in the TFR cell subset can lead to systemic autoimmunity. We will also investigate the related hypothesis that while defects in TFR cells can fuel aberrant autoantibody production, the simultaneous expansion of non-TFR effector Tregs can help limit the tissue damage promoted by these autoAbs. Specifically we will: 1) Delineate the regulation and role of mTORC1-dependent translational programming in TFH cells, and 2) Dissect the pathways controlling effector Treg subsets in lupus. While transcriptional abnormalities in SLE have been extensively investigated, the impact of aberrant translational mechanisms on the function of lupus T cells has received little attention. These studies will thus provide critical information on a new area of investigation and potentially uncover novel targets for therapeutic intervention. A better understanding of the involvement of different Treg subsets in lupus could furthermore provide new insights into the heterogeneity that accompanies this disease as well as important information for the generation of functional Tregs ex vivo, which could be optimally suited to specifically target SLE.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms controlling ABC differentiation and function in SLE
  • 批准号:
    10364120
  • 项目类别:
  • 资助金额:
    $56.96万
  • 财政年份:
    2022
  • 负责人:
    ALESSANDRA B PERNIS
  • 依托单位:
Mechanisms controlling ABC differentiation and function in SLE
  • 批准号:
    10620619
  • 项目类别:
  • 资助金额:
    $56.96万
  • 财政年份:
    2022
  • 负责人:
    ALESSANDRA B PERNIS
  • 依托单位:
FASEB SRC on Autoimmunity
HSS Research Institute Rheumatology Training
  • 批准号:
    10615785
  • 项目类别:
  • 资助金额:
    $36.32万
  • 财政年份:
    2017
  • 负责人:
    ALESSANDRA B PERNIS
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: